There is an "interesting" review in the latest Economist about a book (that is to be released within weeks) about Big Pharma and Big Pharmas' connections to the various regulatory authorities ... in essence the Economist scathingly opines that on the basis of the evidence and information presented in the book it is scandalous that there are so many questionable unsavoury decisions made within the regulatory bodies as well as corruption.
TIS Price at posting:
40.0¢ Sentiment: Hold Disclosure: Held